Type One Diabetes and the Pathway to Peak Performance with Erin Keyes, MPH, MBA

In this episode of The Pathway to Peak Performance, Jock Putney sits down with epidemiologist and health innovator Erin Keyes, MPH, MBA to explore how Type 1 diabetes, precision medicine, AI, and cellular health intersect to shape the future of human performance.Drawing from her lived experience with Type 1 diabetes and her career across public health, healthcare systems, and startups, Erin shares why traditional “sick care” isn’t enough—and how environment, metabolism, insulin sensitivity, and access profoundly influence long-term outcomes.This grounded and forward-thinking conversation breaks down what it truly takes to build a healthier, higher-performing society through science, compassion, and innovation.This episode supports Breakthrough T1D, funding global Type 1 diabetes research, advocacy, and community programs.Donate here: https://www.breakthrought1d.org/If this conversation resonates, please like, share, subscribe, and pass it along to someone passionate about the future of health and performance.Follow Jock on Instagram: https://www.instagram.com/jfp_cubed/What You’ll Learn in This EpisodeThe differences between Type 1, Type 2, and pre-diabetesHow metabolism, insulin sensitivity, and the exposome influence healthThe promise—and limits—of peptides and cellular medicineWhere AI can meaningfully transform diagnostics, prevention, and care deliveryWhy cost, access, and policy continue to challenge long-term outcomesThe lived reality of managing Type 1 diabetesHow empathy, parenting, and personal environments shape health decisionsPractical insights into building a high-performance lifestyle